升主动脉尺寸在非复杂性急性B型主动脉夹层患者结局中的作用
本研究回顾性分析2000年6月至2015年1月收治的非复杂性急性B型主动脉夹层(uATBAD)患者,纳入131例有影像学随访者,评估升主动脉最大直径和面积与结局的关联。结果显示升主动脉面积>12.1 cm²或直径>40.8 mm与后续弓部及近端进展需开放升主动脉修复相关,并预测无干预生存率降低,但控制全长主动脉最大直径>44 mm等因素后不显著预测死亡。
要点
- 升主动脉面积>12.1 cm²或直径>40.8 mm的uATBAD患者弓部及近端进展风险高。
- 升主动脉直径>40.8 mm预测无干预生存率降低(P=0.01),但不预测总生存(P=0.12)。
- 控制全长主动脉最大直径>44 mm等因素后,升主动脉尺寸不显著预测死亡。
核心结论
- 升主动脉面积>12.1 cm²或最大升主动脉直径>40.8 mm的uATBAD患者后续弓部及近端进展风险高,可能需要更密切随访或更早干预。
- 升主动脉尺寸(直径和面积)可预测uATBAD患者无干预生存率降低。
研究设计与样本
- 回顾性分析2000年6月至2015年1月收治的uATBAD患者,纳入有可用影像学检查者。
- 共298例uATBAD患者入院,238例有计算机断层扫描(CT),131例有CT血管造影(CTA)且随访充分可供分析。
- 队列平均年龄60.96±13.4岁,男性占60%,白人占53%。
- 所有测量由专门的心血管放射科医生完成,包括最大升主动脉直径和面积。
- 采用分层Kaplan-Meier和多因素Cox回归分析,使用SAS 9.4软件。
主要发现
- 升主动脉面积>12.1 cm²和升主动脉直径>40.8 mm与后续弓部及近端进展需开放升主动脉修复相关(P<0.027和P<0.033)。
- 升主动脉直径>40.8 mm预测无干预生存率降低(P=0.01),但不预测总生存(P=0.12)。
- 升主动脉面积>12.1 cm²预测无干预生存率降低(P=0.005),但不预测死亡(P=0.08)。
- 全长主动脉最大直径>44 mm是死亡的持续危险因素(P<0.001)。
- 控制全长主动脉最大直径>44 mm(HR 7.34;95%CI 2.3-23.41;P<0.001)、糖尿病(HR 6.4;95%CI 2.17-18.93;P<0.001)、年龄(HR 1.06/岁;95%CI 1.03-1.10;P<0.001)、卒中史(HR 5.03;95%CI 1.52-16.63;P=0.008)和入院时晕厥(HR 21.11;95%CI 2.3-193.84;P=0.007)后,升主动脉直径>40.8 mm(HR 1.09;95%CI 0.42-2.83;P=0.85)和面积>12.1 cm²(HR 0.992;95%CI 0.38-2.61;P=0.99)均不显著预测死亡。
关键数值与推荐
- 升主动脉面积>12.1 cm²与后续弓部及近端进展需开放升主动脉修复相关(P<0.027)。
- 升主动脉直径>40.8 mm与后续弓部及近端进展需开放升主动脉修复相关(P<0.033)。
- 升主动脉直径>40.8 mm预测无干预生存率降低(P=0.01),但不预测总生存(P=0.12)。
- 升主动脉面积>12.1 cm²预测无干预生存率降低(P=0.005),但不预测死亡(P=0.08)。
- 控制全长主动脉最大直径>44 mm(HR 3.142;95%CI 1.47-6.83;P<0.004)、入院时晕厥(HR 26.3;95%CI 2.81-246;P<0.004)和入院时胸腔积液(HR 3.02;95%CI 1.58-5.77;P<0.001)后,升主动脉直径>40.8 mm(HR 2.01;95%CI 1.03-3.95;P=0.04)和最大升主动脉面积>12.1 cm²(HR 1.988;95%CI 1.02-3.87;P=0.04)仍是无干预生存率降低的预测因素。
临床怎么用
- 作者认为,升主动脉面积>12.1 cm²或最大升主动脉直径>40.8 mm的uATBAD患者可能需要更密切随访或更早干预。
- 升主动脉尺寸(直径和面积)可预测uATBAD患者无干预生存率降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent studies demonstrate that uncomplicated acute type B aortic dissection (uATBAD) patients with enlarged descending thoracic aortic diameters are at high risk for development of complications. This study aimed to determine the association of maximum ascending aortic diameter and area and outcomes in patients with uATBAD. METHODS: All patients admitted with uATBAD from June 2000 to January 2015 were reviewed, and those with available imaging were included. All measurements were obtained by a specialized cardiovascular radiologist, including the maximum ascending aortic diameter and area. Outcomes, including the need for intervention and mortality, were tracked over time. Data were analyzed by stratified Kaplan-Meier and multiple Cox regression analyses using SAS 9.4 software (SAS Institute, Cary, NC). RESULTS: During the study period, 298 patients with uATBAD were admitted, with 238 having available computed tomography and 131 having computed tomography angiography imaging and adequate follow-up available for analysis. The cohort had an average age of 60.96 ± 13.4 years (60% male, 53% white). Ascending aortic area >12.1 cm2 and ascending aortic diameter >40.8 mm were associated with subsequent arch and proximal progression necessitating open ascending aortic repair (P < .027 and P < .033, respectively). Ascending diameter >40.8 mm predicted lower intervention-free survival (P = .01). However, it failed to predict overall survival (P = .12). Ascending aortic area >12.1 cm2 predicted lower intervention-free survival (P = .005). However, this was not predictive of mortality (P = .08). Maximum aortic diameter along the length of the aorta >44 mm persisted as a risk factor for mortality (P < .001). Neither maximum ascending aortic diameter >40.8 mm (hazard ratio [HR], 1.09; 95% confidence interval [CI], 0.42-2.83; P = .85) nor area >12.1 cm2 (HR, 0.992; 95% CI, 0.38-2.61; P = .99) significantly predicted mortality when controlling for maximum aortic diameter along the length of the aorta >44 mm (HR, 7.34; 95% CI, 2.3-23.41; P < .001), diabetes mellitus (HR, 6.4; 95% CI, 2.17-18.93; P < .001), age (HR, 1.06/y; 95% CI, 1.03-1.10; P < .001), history of stroke (HR, 5.03; 95% CI, 1.52-16.63; P = .008), and syncope on admission (HR, 21.11; 95% CI, 2.3-193.84; P = .007). Ascending aortic diameter >40.8 mm (HR, 2.01; 95% CI, 1.03-3.95; P = .04) and maximum ascending aortic area >12.1 cm2 (HR, 1.988; 95% CI, 1.02-3.87; P = .04) on admission persisted as predictors of decreased intervention-free survival after controlling for maximum aortic diameter along the length of the aorta >44 mm (HR, 3.142; 95% CI, 1.47-6.83; P < .004), syncope on admission (HR, 26.3; 95% CI, 2.81-246; P < .004), and pleural effusion on admission (HR, 3.02; 95% CI, 1.58-5.77; P < .001). CONCLUSIONS: uATBAD patients with ascending aortic area >12.1 cm2 or maximum ascending aortic diameter >40.8 mm are at high risk for development of subsequent arch and proximal progression and may require closer follow-up or earlier intervention. Ascending aortic size (diameter and area) is predictive of decreased intervention-free survival in patients with uATBAD.
引用
- Ray HM, Besho JM, Au J, et al. The role of ascending aortic size in outcomes of patients with uncomplicated acute type B aortic dissection. J Vasc Surg. 2018. PMID: 30301688. doi:10.1016/j.jvs.2018.07.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。